-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Athira Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2024.
- Athira Pharma, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$27.7 M, a 7% increase year-over-year.
- Athira Pharma, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$123 M, a 11.8% decline year-over-year.
- Athira Pharma, Inc. annual Operating Income (Loss) for 2023 was -$125 M, a 20.6% decline from 2022.
- Athira Pharma, Inc. annual Operating Income (Loss) for 2022 was -$104 M, a 62.5% decline from 2021.
- Athira Pharma, Inc. annual Operating Income (Loss) for 2021 was -$64 M, a 220% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)